Pressure mounts at GSK, with U.S. hedge fund leading calls for exec shakeup

Tracy Staton

Another big investor is putting the screws to GlaxoSmith Kline. Och-Ziff Capital Management has built up a sizable stake in the London-based drugmaker, The Sunday Times reports, and officials are leaning on Chairman Philip Hampton to shake up management.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2019 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS